PG
PG
The Procter & Gamble CompanyIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2026 | $21.23B ▼ | $5.94B ▼ | $3.97B ▼ | 18.69% ▼ | $1.66 ▼ | $5.21B ▼ |
| Q2-2026 | $22.21B ▼ | $6.01B ▲ | $4.33B ▼ | 19.5% ▼ | $1.82 ▼ | $5.6B ▼ |
| Q1-2026 | $22.39B ▲ | $5.64B ▼ | $4.75B ▲ | 21.22% ▲ | $2 ▲ | $6.99B ▲ |
| Q4-2025 | $20.89B ▲ | $5.9B ▲ | $3.62B ▼ | 17.31% ▼ | $1.51 ▼ | $5.46B ▼ |
| Q3-2025 | $19.78B | $5.52B | $3.77B | 19.06% | $1.58 | $5.57B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2026 | $12.31B ▲ | $128.38B ▲ | $73.65B ▼ | $54.51B ▲ |
| Q2-2026 | $10.82B ▼ | $127.29B ▼ | $73.97B ▼ | $53.32B ▲ |
| Q1-2026 | $11.17B ▲ | $127.6B ▲ | $74.05B ▲ | $53.27B ▲ |
| Q4-2025 | $9.56B ▲ | $125.23B ▲ | $72.95B ▲ | $52.01B ▼ |
| Q3-2025 | $9.12B | $122.98B | $70.44B | $52.27B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2026 | $3.95B ▼ | $4.04B ▼ | $-665M ▲ | $-1.83B ▲ | $1.48B ▲ | $3.03B ▼ |
| Q2-2026 | $4.33B ▼ | $4.97B ▼ | $-1.23B ▲ | $-4.09B ▼ | $-346M ▼ | $3.81B ▼ |
| Q1-2026 | $4.78B ▲ | $5.41B ▲ | $-1.53B ▼ | $-2.24B ▲ | $1.61B ▲ | $4.21B ▲ |
| Q4-2025 | $3.63B ▼ | $4.99B ▲ | $-1.06B ▼ | $-3.62B ▲ | $440M ▲ | $3.99B ▲ |
| Q3-2025 | $3.79B | $3.71B | $-726M | $-4.21B | $-1.11B | $2.85B |
Revenue by Products
| Product | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|
Baby Feminine and Family Care Segment Member | $5.09Bn ▲ | $5.17Bn ▲ | $5.12Bn ▼ | $5.06Bn ▼ |
Beauty Segment | $3.73Bn ▲ | $4.14Bn ▲ | $4.04Bn ▼ | $3.87Bn ▼ |
Fabric Care And Home Care Segment Member | $7.38Bn ▲ | $7.79Bn ▲ | $7.69Bn ▼ | $7.40Bn ▼ |
Grooming Segment Member | $1.68Bn ▲ | $1.82Bn ▲ | $1.79Bn ▼ | $1.61Bn ▼ |
Health Care Segment Member | $2.72Bn ▲ | $3.22Bn ▲ | $3.41Bn ▲ | $3.07Bn ▼ |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at The Procter & Gamble Company's financial evolution and strategic trajectory over the past five years.
P&G’s core strengths include a powerful portfolio of trusted brands, strong and stable margins, and steady growth in earnings. Its balance sheet is anchored by growing retained earnings and a solid equity base, while its business model generates substantial cash even in a softer cash conversion environment. Large-scale, disciplined operations, combined with a deep innovation capability and global reach, give it significant advantages in negotiating with retailers and defending market share.
Key risks center on rising leverage, a gradually weaker conversion of earnings into cash, and the inherently tough competitive landscape in consumer staples. Higher capital spending and R&D need to pay off in renewed growth, or they could compress free cash flow over time. Intense competition from global peers, private labels, and smaller disruptive brands, along with shifting consumer preferences and sustainability expectations, could pressure volumes or pricing if P&G’s innovation and marketing miss the mark. Macroeconomic factors and currency swings add further uncertainty.
The overall outlook is for continued steady, rather than spectacular, progress, with resilience grounded in everyday essential products and strong brands. If P&G can translate its elevated investment in innovation, capacity, and digital capabilities into improved volume growth and stronger cash generation, it is well positioned to sustain solid profitability and ongoing shareholder returns. The main areas to monitor are cash flow trends, leverage levels, and evidence that new products and sustainability initiatives are driving tangible market share and pricing benefits over time.
About The Procter & Gamble Company
http://us.pg.comThe Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2026 | $21.23B ▼ | $5.94B ▼ | $3.97B ▼ | 18.69% ▼ | $1.66 ▼ | $5.21B ▼ |
| Q2-2026 | $22.21B ▼ | $6.01B ▲ | $4.33B ▼ | 19.5% ▼ | $1.82 ▼ | $5.6B ▼ |
| Q1-2026 | $22.39B ▲ | $5.64B ▼ | $4.75B ▲ | 21.22% ▲ | $2 ▲ | $6.99B ▲ |
| Q4-2025 | $20.89B ▲ | $5.9B ▲ | $3.62B ▼ | 17.31% ▼ | $1.51 ▼ | $5.46B ▼ |
| Q3-2025 | $19.78B | $5.52B | $3.77B | 19.06% | $1.58 | $5.57B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2026 | $12.31B ▲ | $128.38B ▲ | $73.65B ▼ | $54.51B ▲ |
| Q2-2026 | $10.82B ▼ | $127.29B ▼ | $73.97B ▼ | $53.32B ▲ |
| Q1-2026 | $11.17B ▲ | $127.6B ▲ | $74.05B ▲ | $53.27B ▲ |
| Q4-2025 | $9.56B ▲ | $125.23B ▲ | $72.95B ▲ | $52.01B ▼ |
| Q3-2025 | $9.12B | $122.98B | $70.44B | $52.27B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2026 | $3.95B ▼ | $4.04B ▼ | $-665M ▲ | $-1.83B ▲ | $1.48B ▲ | $3.03B ▼ |
| Q2-2026 | $4.33B ▼ | $4.97B ▼ | $-1.23B ▲ | $-4.09B ▼ | $-346M ▼ | $3.81B ▼ |
| Q1-2026 | $4.78B ▲ | $5.41B ▲ | $-1.53B ▼ | $-2.24B ▲ | $1.61B ▲ | $4.21B ▲ |
| Q4-2025 | $3.63B ▼ | $4.99B ▲ | $-1.06B ▼ | $-3.62B ▲ | $440M ▲ | $3.99B ▲ |
| Q3-2025 | $3.79B | $3.71B | $-726M | $-4.21B | $-1.11B | $2.85B |
Revenue by Products
| Product | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|
Baby Feminine and Family Care Segment Member | $5.09Bn ▲ | $5.17Bn ▲ | $5.12Bn ▼ | $5.06Bn ▼ |
Beauty Segment | $3.73Bn ▲ | $4.14Bn ▲ | $4.04Bn ▼ | $3.87Bn ▼ |
Fabric Care And Home Care Segment Member | $7.38Bn ▲ | $7.79Bn ▲ | $7.69Bn ▼ | $7.40Bn ▼ |
Grooming Segment Member | $1.68Bn ▲ | $1.82Bn ▲ | $1.79Bn ▼ | $1.61Bn ▼ |
Health Care Segment Member | $2.72Bn ▲ | $3.22Bn ▲ | $3.41Bn ▲ | $3.07Bn ▼ |
Q3 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at The Procter & Gamble Company's financial evolution and strategic trajectory over the past five years.
P&G’s core strengths include a powerful portfolio of trusted brands, strong and stable margins, and steady growth in earnings. Its balance sheet is anchored by growing retained earnings and a solid equity base, while its business model generates substantial cash even in a softer cash conversion environment. Large-scale, disciplined operations, combined with a deep innovation capability and global reach, give it significant advantages in negotiating with retailers and defending market share.
Key risks center on rising leverage, a gradually weaker conversion of earnings into cash, and the inherently tough competitive landscape in consumer staples. Higher capital spending and R&D need to pay off in renewed growth, or they could compress free cash flow over time. Intense competition from global peers, private labels, and smaller disruptive brands, along with shifting consumer preferences and sustainability expectations, could pressure volumes or pricing if P&G’s innovation and marketing miss the mark. Macroeconomic factors and currency swings add further uncertainty.
The overall outlook is for continued steady, rather than spectacular, progress, with resilience grounded in everyday essential products and strong brands. If P&G can translate its elevated investment in innovation, capacity, and digital capabilities into improved volume growth and stronger cash generation, it is well positioned to sustain solid profitability and ongoing shareholder returns. The main areas to monitor are cash flow trends, leverage levels, and evidence that new products and sustainability initiatives are driving tangible market share and pricing benefits over time.

CEO
Shailesh G. Jejurikar
Compensation Summary
(Year )
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2004-06-21 | Forward | 2:1 |
| 1997-09-22 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 1,001
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
UBS
Buy
Wells Fargo
Overweight
Evercore ISI Group
In Line
TD Cowen
Hold
JP Morgan
Overweight
Barclays
Equal Weight
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
METATRON CAPITAL SICAV PLC
Shares:2.4B
Value:$344.15B
VANGUARD GROUP INC
Shares:237.46M
Value:$34.09B
BLACKROCK, INC.
Shares:187.03M
Value:$26.85B
Summary
Showing Top 3 of 5,312

